Hypoglycemic and hypolipidemic effect of S-allyl-cysteine sulfoxide (alliin) in DIO mice

Sci Rep. 2018 Feb 23;8(1):3527. doi: 10.1038/s41598-018-21421-x.

Abstract

Alliin (S-allyl cysteine sulfoxide) is a bioactive sulfoxide compound derived from garlic. To evaluate the preventive effect of alliin against metabolic risk factors in diet induced obese (DIO) mice, we treated the C57BL/6J DIO mice with drinking water with or without alliin (0.1 mg/ml) for 8 weeks. Results showed that alliin had no significant effect on the body weight, adiposity or energy balance. However, alliin treatment enhanced glucose homeostasis, increased insulin sensitivity and improved the lipid profile in the DIO mice. This was, at least partly, attributable to alliin induced modulation of the intestinal microbiota composition, typically decreased Lachnospiraceae and increased Ruminococcaceae. From above, we conclude that alliin has nutraceutical or even medicinal potential in prevention of diabetes and lipid metabolic disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Body Composition
  • Body Weight
  • Clostridiales / classification
  • Clostridiales / drug effects
  • Clostridiales / physiology
  • Cysteine / analogs & derivatives*
  • Cysteine / pharmacology
  • Diet, High-Fat / adverse effects
  • Drinking Water / administration & dosage
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / physiology
  • Glucose / metabolism*
  • Glucose Tolerance Test
  • Homeostasis / physiology
  • Hyperlipidemias / drug therapy*
  • Hyperlipidemias / etiology
  • Hyperlipidemias / metabolism
  • Hyperlipidemias / physiopathology
  • Hypoglycemic Agents / pharmacology*
  • Hypolipidemic Agents / pharmacology*
  • Insulin / metabolism
  • Insulin Resistance / physiology
  • Liver / drug effects
  • Liver / metabolism
  • Liver / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / drug therapy*
  • Obesity / etiology
  • Obesity / metabolism
  • Obesity / physiopathology
  • Subcutaneous Fat / drug effects
  • Subcutaneous Fat / metabolism
  • Subcutaneous Fat / physiopathology

Substances

  • Drinking Water
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Insulin
  • alliin
  • Glucose
  • Cysteine